• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模块化改进的Sympatec HELOS对基于载体的干粉吸入器经肺途径给药过程进行实时监测的新方法。

Novel approach for real-time monitoring of carrier-based DPIs delivery process pulmonary route based on modular modified Sympatec HELOS.

作者信息

Zhang Xuejuan, Cui Yingtong, Liang Ruifeng, Wang Guanlin, Yue Xiao, Zhao Ziyu, Huang Zhengwei, Huang Ying, Geng Jianfang, Pan Xin, Wu Chuanbin

机构信息

School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.

Institute for Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.

出版信息

Acta Pharm Sin B. 2020 Jul;10(7):1331-1346. doi: 10.1016/j.apsb.2020.02.013. Epub 2020 Mar 4.

DOI:10.1016/j.apsb.2020.02.013
PMID:32874832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7452036/
Abstract

An explicit illustration of pulmonary delivery processes (PDPs) was a prerequisite for the formulation design and optimization of carrier-based DPIs. However, the current evaluation approaches for DPIs could not provide precise investigation of each PDP separately, or the approaches merely used a simplified and idealized model. In the present study, a novel modular modified Sympatec HELOS (MMSH) was developed to fully investigate the mechanism of each PDP separately in real-time. An inhaler device, artificial throat and pre-separator were separately integrated with a Sympatec HELOS. The dispersion and fluidization, transportation, detachment and deposition processes of pulmonary delivery for model DPIs were explored under different flow rates. Moreover, time-sliced measurements were used to monitor the PDPs in real-time. The Next Generation Impactor (NGI) was applied to determine the aerosolization performance of the model DPIs. The release profiles of the drug particles, drug aggregations and carriers were obtained by MMSH in real-time. Each PDP of the DPIs was analyzed in detail. Moreover, a positive correlation was established between the total release amount of drug particles and the fine particle fraction (FPF) values (  = 0.9898). The innovative MMSH was successfully developed and was capable of illustrating the PDPs and the mechanism of carrier-based DPIs, providing a theoretical basis for the design and optimization of carrier-based DPIs.

摘要

明确阐述肺部递送过程(PDPs)是基于载体的干粉吸入剂(DPIs)制剂设计和优化的前提条件。然而,目前对DPIs的评估方法无法分别对每个PDP进行精确研究,或者这些方法仅使用简化和理想化的模型。在本研究中,开发了一种新型模块化改进的Sympatec HELOS(MMSH),以实时分别全面研究每个PDP的机制。将吸入装置、人工喉和预分离器分别与Sympatec HELOS集成。在不同流速下探索了模型DPIs肺部递送的分散与流化、运输、分离和沉积过程。此外,采用时间切片测量来实时监测PDPs。应用下一代撞击器(NGI)来测定模型DPIs的雾化性能。通过MMSH实时获得药物颗粒、药物聚集体和载体的释放曲线。详细分析了DPIs的每个PDP。此外,在药物颗粒的总释放量与细颗粒分数(FPF)值之间建立了正相关(r = 0.9898)。成功开发了创新的MMSH,其能够阐明PDPs以及基于载体的DPIs的机制,为基于载体的DPIs的设计和优化提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/e771b07979ff/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/e1ddf98fb270/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/35645b416cb8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/3a63d4ce5c3e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/b0dcf175da7a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/4ca2ec148862/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/38e4739c9e96/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/86fefc5140d4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/1a181f387c01/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/e771b07979ff/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/e1ddf98fb270/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/35645b416cb8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/3a63d4ce5c3e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/b0dcf175da7a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/4ca2ec148862/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/38e4739c9e96/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/86fefc5140d4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/1a181f387c01/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f87/7452036/e771b07979ff/gr8.jpg

相似文献

1
Novel approach for real-time monitoring of carrier-based DPIs delivery process pulmonary route based on modular modified Sympatec HELOS.基于模块化改进的Sympatec HELOS对基于载体的干粉吸入器经肺途径给药过程进行实时监测的新方法。
Acta Pharm Sin B. 2020 Jul;10(7):1331-1346. doi: 10.1016/j.apsb.2020.02.013. Epub 2020 Mar 4.
2
A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes.一种用于快速检测不同载体颗粒尺寸的干粉吸入剂并探索其作用机制的实时模块化方法。
Acta Pharm Sin B. 2022 Jan;12(1):437-450. doi: 10.1016/j.apsb.2021.06.011. Epub 2021 Jun 21.
3
Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.CFD 结合拉格朗日粒子追踪在干粉吸入器中应用的潜力和限制。
Eur J Pharm Sci. 2019 Feb 1;128:299-324. doi: 10.1016/j.ejps.2018.12.008. Epub 2018 Dec 14.
4
Influence of physical properties of carrier on the performance of dry powder inhalers.载体物理性质对干粉吸入器性能的影响。
Acta Pharm Sin B. 2016 Jul;6(4):308-18. doi: 10.1016/j.apsb.2016.03.011. Epub 2016 May 4.
5
Investigation of dry powder aerosolization mechanisms in different channel designs.不同通道设计下干粉气溶胶化机制的研究。
Int J Pharm. 2013 Nov 30;457(1):143-9. doi: 10.1016/j.ijpharm.2013.09.012. Epub 2013 Sep 18.
6
Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).针对干粉吸入器(DPI),评估简化撞击器测量法(AIM)和高效数据分析(EDA)与全分辨率下一代撞击器(NGI)的对比情况。
AAPS PharmSciTech. 2017 Jul;18(5):1585-1594. doi: 10.1208/s12249-016-0625-9. Epub 2016 Sep 13.
7
Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.定量压力吸入气雾剂的气溶胶空气动力学粒径分析:Andersen八级阶式撞击器、新一代药物撞击器和3321型空气动力学粒径分析仪的比较
AAPS PharmSciTech. 2003 Oct 22;4(4):E54. doi: 10.1208/pt040454.
8
Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.新型抗生素干粉吸入剂制剂,采用联合技术改善空气动力学性能。
Eur J Pharm Sci. 2018 Oct 15;123:20-27. doi: 10.1016/j.ejps.2018.07.030. Epub 2018 Jul 17.
9
CFD-DEM investigation of the effects of aperture size for a capsule-based dry powder inhaler.基于胶囊的干粉吸入器孔径大小对其影响的 CFD-DEM 研究。
Int J Pharm. 2023 Nov 25;647:123556. doi: 10.1016/j.ijpharm.2023.123556. Epub 2023 Oct 26.
10
Effect of sampling volume on dry powder inhaler (DPI)-emitted aerosol aerodynamic particle size distributions (APSDs) measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen eight-stage cascade impactor (ACI).采样体积对下一代药物撞击器(NGI)和安德森八级级联撞击器(ACI)测量的干粉吸入器(DPI)发射气溶胶空气动力学粒径分布(APSD)的影响。
AAPS PharmSciTech. 2012 Sep;13(3):875-82. doi: 10.1208/s12249-012-9797-0. Epub 2012 Jun 8.

引用本文的文献

1
Resveratrol inhibits ferroptosis in the lung tissues of heat stroke-induced rats via the Nrf2 pathway.白藜芦醇通过 Nrf2 通路抑制热射病诱导的大鼠肺组织中的铁死亡。
BMC Pharmacol Toxicol. 2024 Nov 19;25(1):88. doi: 10.1186/s40360-024-00810-1.
2
Pulmonary delivery of resveratrol--cyclodextrin inclusion complexes for the prevention of zinc chloride smoke-induced acute lung injury.利用环糊精包合物经肺部给药递送白藜芦醇预防氯化锌烟雾诱导的急性肺损伤。
Drug Deliv. 2022 Dec;29(1):1122-1131. doi: 10.1080/10717544.2022.2048135.
3
A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes.

本文引用的文献

1
Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.喷雾干燥用于囊性纤维化生物膜治疗的可吸入多功能制剂。
J Control Release. 2019 Nov 28;314:62-71. doi: 10.1016/j.jconrel.2019.10.038. Epub 2019 Oct 22.
2
Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.PEG 化 KL4 合成肽干粉制剂经肺部给药实现有效 mRNA 传递
J Control Release. 2019 Nov 28;314:102-115. doi: 10.1016/j.jconrel.2019.10.026. Epub 2019 Oct 16.
3
A comparative analysis of changes in pMDI drug dose delivery before and after detergent coating using five antistatic valved holding chambers.
一种用于快速检测不同载体颗粒尺寸的干粉吸入剂并探索其作用机制的实时模块化方法。
Acta Pharm Sin B. 2022 Jan;12(1):437-450. doi: 10.1016/j.apsb.2021.06.011. Epub 2021 Jun 21.
4
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era.基于膜破坏肽/肽模拟物的疗法:在耐药时代对抗细菌和癌症的有前景的系统。
Acta Pharm Sin B. 2021 Sep;11(9):2609-2644. doi: 10.1016/j.apsb.2021.07.014. Epub 2021 Jul 21.
使用五个抗静电储雾罐对洗涤剂涂层前后压力定量吸入器药物剂量递送变化的比较分析。
J Allergy Clin Immunol Pract. 2020 Mar;8(3):1124-1125.e4. doi: 10.1016/j.jaip.2019.09.021. Epub 2019 Oct 5.
4
Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler.预测双支气管扩张剂干粉吸入器肺部给药的生物物理模型。
Int J Pharm X. 2019 May 30;1:100018. doi: 10.1016/j.ijpx.2019.100018. eCollection 2019 Dec.
5
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.注射用黏菌素硫酸沙丁胺醇干粉吸入剂治疗囊性纤维化肺部感染:粉末构建的优化。
Drug Dev Ind Pharm. 2019 Oct;45(10):1664-1673. doi: 10.1080/03639045.2019.1652636. Epub 2019 Aug 30.
6
Cascade Impactor Equivalence Testing: Comparison of the Performance of the Modified Chi-Square Ratio Statistic (mCSRS) with the Original CSRS and EMA's Average Bioequivalence Approach.级联撞击器等效性测试:改良卡方比统计量(mCSRS)与原始 CSRS 和 EMA 的平均生物等效性方法的性能比较。
AAPS PharmSciTech. 2019 Jul 8;20(6):249. doi: 10.1208/s12249-019-1443-7.
7
Most frequent errors in inhalation technique of patients with asthma treated at a tertiary care hospital.在一家三级护理医院接受治疗的哮喘患者吸入技术中最常见的错误。
Einstein (Sao Paulo). 2019 May 2;17(2):eAO4397. doi: 10.31744/einstein_journal/2019AO4397.
8
Linking carrier morphology to the powder mechanics of adhesive mixtures for dry powder inhalers via a blend-state model.通过混合状态模型将载体形态与干粉吸入器用粘性混合物的粉末力学联系起来。
Int J Pharm. 2019 Apr 20;561:148-160. doi: 10.1016/j.ijpharm.2019.02.038. Epub 2019 Feb 28.
9
Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.CFD 结合拉格朗日粒子追踪在干粉吸入器中应用的潜力和限制。
Eur J Pharm Sci. 2019 Feb 1;128:299-324. doi: 10.1016/j.ejps.2018.12.008. Epub 2018 Dec 14.
10
Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers.使用脂质体姜黄素干粉吸入器对原发性肺癌进行吸入治疗。
Acta Pharm Sin B. 2018 May;8(3):440-448. doi: 10.1016/j.apsb.2018.03.004. Epub 2018 May 3.